The lay version of the Eurocrine final report on standards of care for surgically treated rare endocrine tumours, is now publicly available. The document can be reached by clicking the link:


The newly released module, My Eurocrine,is a novel feature to the database, which provides the user with additional unique flexibility to tailor the database to local needs. With this new feature you can create your own variables for collection of data, perform observational studies, and randomised controlled trials (RCT:s).

  • Create your own variables
  • Select the time frame
  • Define screening criteria
  • Set up inclusion / exclusion criteria
  • Attach documents (as required)
  • For RCT:s; Automatic randomisation
  • Ínvite other clinics to join

The Eurocrine registry reached 1 000 registered operations in the start of 2016, and have now passed 1 500 operations. There is still time for participation in the first analysis - if your clinic start now. 24 clinics from 12 countries are participating with data.

The collection of data has started on all diagnoses groups: thyroid, primary and secondary hyperparathyroidism, paraganglioma, adrenal tumours, and GEP-NET. The following working languages are available: English, French, German, Italian, Polish, Spanish, and Turkish.

To sign up and for enquiries - Please contact the coordinator for the project.

Identify best practice – Compiled data makes it possible to compare effectiveness in preoperative work-up, operation, surgical treatment, and outcome.

Benchmark yourself – Compare your outcome data with that of your country and the rest of Europe.

Start research projects – Collaborate across Europe in unique research projects.

Define variables to collect – Choose  extra variables to collect and predefine lead texts, field types, formats, and value intervals.

Make your own surveys – collect extra data for groups of diagnoses within a certain time period, with the variables you create yourself

Take part in a European network.

Free of charge – Until the end of 2016, participation is free of charge, with no obligation to continue. From 2017, financed by membership fees (non-profit).